0001615219-20-000027.txt : 20200325 0001615219-20-000027.hdr.sgml : 20200325 20200325180305 ACCESSION NUMBER: 0001615219-20-000027 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200323 FILED AS OF DATE: 20200325 DATE AS OF CHANGE: 20200325 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rosenblum Mark J CENTRAL INDEX KEY: 0001329154 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36812 FILM NUMBER: 20743411 MAIL ADDRESS: STREET 1: 3990 SPRING VALLEY ROAD, APT. 1218 CITY: DALLAS STATE: TX ZIP: 75244 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Salarius Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001615219 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465087339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2450 HOLCOMBE BLVD STREET 2: SUITE J-608 CITY: HOUSTON STATE: TX ZIP: 77021 BUSINESS PHONE: 346-772-0346 MAIL ADDRESS: STREET 1: 2450 HOLCOMBE BLVD STREET 2: SUITE J-608 CITY: HOUSTON STATE: TX ZIP: 77021 FORMER COMPANY: FORMER CONFORMED NAME: Flex Pharma, Inc. DATE OF NAME CHANGE: 20140730 4 1 wf-form4_158517376702567.xml FORM 4 X0306 4 2020-03-23 0 0001615219 Salarius Pharmaceuticals, Inc. SLRX 0001329154 Rosenblum Mark J C/O SALARIUS PHARMACEUTICALS, INC. 2450 HOLCOMBE BLVD., SUITE J - 608 HOUSTON TX 77021 0 1 0 0 Exec VP Finance, CFO Common Stock 0.61 2020-03-23 4 A 0 30000 0 A 2030-03-22 Common Stock 30000.0 30000 D 25% of the options granted are fully vested on March 23, 2021, and quarterly vesting of the remaining options over 3 years /s/ Mark J. Rosenblum 2020-03-25